Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial

Overview of attention for article published in Health and Quality of Life Outcomes, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 115 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Vertex Pharmaceuticals Should Earn An Expanded Label For Its Lead Blockbuster Drug

Seeking Alpha, 29 Aug 2016

Vertex Pharmaceuticals (NASDAQ: VRTX ) is a large (market cap of $25.01 billion) global biotechnology company with two products…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.